NYSE:BHCPharmaceuticals
Icahn Appointees' Board Exit Might Change The Case For Investing In Bausch Health Companies (BHC)
On August 14, 2025, Brett M. Icahn and Steven D. Miller, both appointees of the Icahn Group, resigned from Bausch Health Companies' board of directors after the termination of the Appointment and Nomination Agreement.
This development marks a significant shift in the company's corporate governance and may influence investor perspectives on board oversight and future direction.
We'll examine how the simultaneous departure of two Icahn Group board members could influence Bausch Health...